ARCAS

Revolutionizing precision oncology therapeutics

 VISION

At Arcas, we believe learning from every cancer patient and every pre-clinical experiment is the key to accelerating the development of personalized treatments and improving the quality of care. However, in today’s drug development or clinical practice, the full extent of the information genome contains is either not used or is used inefficiently.

One basic hurdle is the lack of knowledge on the opportunities cancer multi-omics sequencing will provide, for example, mutation detection, large-scale alterations, gene expression, and epigenetic changes. We believe that by combining these complex layers of information using AI, we will ensure that each patient gets the best treatment possible.